Toshifumi Tada, Medicago CEO
October 27, 2022 11:45 AM EDTUpdated 01:10 PM
People
R&D

Plant-based Covid-19 vac­cine de­vel­op­er Med­ica­go lay­ing off 60+ at North Car­oli­na plant

Paul Schloesser

Associate Editor

Med­ica­go had been look­ing at, among oth­er things, a plant-based vac­cine for Covid-19. But those plans aren’t go­ing in the di­rec­tion Med­ica­go want­ed to. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times